Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Kimberly-Clark Corporation Stock (KMB) Opinions on Kenvue Acquisition

None

Kenvue Acquisition Shock: Kimberly-Clark Corporation's stock took a significant hit on X discussions following the announcement of a $49 billion stock-and-cash acquisition of Kenvue. Many users expressed concern over the 16% pre-market plunge in share price, questioning the deal's impact on long-term value. The scale of the merger, aiming for a combined revenue of $32 billion, has sparked intense debate.

Strategic Move or Risky Bet: Posts on X highlight a divide, with some seeing the acquisition as a bold step to dominate personal care and consumer health markets. Others worry about the $15.8 billion net debt and potential legal risks tied to the deal. The market's reaction, including analyst downgrades, fuels ongoing skepticism among observers.

Note: This discussion summary was generated from an AI condensation of post data.

Kimberly-Clark Corporation Insider Trading Activity

KMB Insider Trades

Kimberly-Clark Corporation insiders have traded $KMB stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $KMB stock by insiders over the last 6 months:

  • ZACKERY A HICKS (Chief Digital & Technology Off) sold 15,038 shares for an estimated $2,006,117

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Kimberly-Clark Corporation Congressional Stock Trading

Members of Congress have traded $KMB stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $KMB stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Kimberly-Clark Corporation Hedge Fund Activity

We have seen 707 institutional investors add shares of Kimberly-Clark Corporation stock to their portfolio, and 845 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Kimberly-Clark Corporation Analyst Ratings

Wall Street analysts have issued reports on $KMB in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Piper Sandler issued a "Overweight" rating on 10/02/2025

To track analyst ratings and price targets for Kimberly-Clark Corporation, check out Quiver Quantitative's $KMB forecast page.

Kimberly-Clark Corporation Price Targets

Multiple analysts have issued price targets for $KMB recently. We have seen 8 analysts offer price targets for $KMB in the last 6 months, with a median target of $130.5.

Here are some recent targets:

  • Peter Grom from UBS set a target price of $132.0 on 10/31/2025
  • Andrea Teixeira from JP Morgan set a target price of $129.0 on 10/31/2025
  • Robert Moskow from TD Cowen set a target price of $130.0 on 10/31/2025
  • Filippo Falorni from Citigroup set a target price of $113.0 on 10/09/2025
  • Michael Lavery from Piper Sandler set a target price of $145.0 on 10/02/2025
  • Lauren Lieberman from Barclays set a target price of $131.0 on 10/01/2025
  • Chris Carey from Wells Fargo set a target price of $130.0 on 09/25/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles